膀胱癌风险评估(COBRA)评分在根治性膀胱切除术后预测癌症特异性生存的外部验证:大型双机构队列研究
本研究在 Leuven 和 Turin 两个机构 1996 年 5 月至 2017 年 7 月间接受根治性膀胱切除加淋巴结清扫的 812 例患者中,对 COBRA 评分预测癌症特异性生存(CSS)进行外部验证。结果显示 COBRA 各评分级别间 CSS 存在重叠,区分度欠佳;研究者构建了简化的三分类 COBRA 模型(低危 0-1、中危 2-4、高危 5-7),各风险组 CSS 无重叠且预测准确性良好。但 COBRA 原始及简化模型均劣于 AJCC 分期系统,AJCC 仍应作为术后 CSS 分层的标准。
要点
- COBRA 评分各原始级别间 CSS 存在重叠,外部验证区分度欠佳。
- 简化 COBRA 三分类(0-1/2-4/5-7)各风险组 CSS 无重叠,预测准确性良好。
- AJCC 分期在 C-index、AUC、校准图和 DCA 上均优于 COBRA 及简化 COBRA 模型。
核心结论
- COBRA 评分外部验证表现欠佳,多个风险组 CSS 重叠;简化三分类模型区分度改善,但 AJCC 分期系统仍应作为根治性膀胱切除术后 CSS 分层的当前标准。
研究设计与样本
- 外部验证研究,纳入 Leuven 和 Turin 两个机构 1996 年 5 月至 2017 年 7 月间接受根治性膀胱切除加淋巴结清扫的 812 例患者。
- 收集变量包括根治性膀胱切除时年龄、肿瘤分期、淋巴结密度、新辅助化疗、淋巴结清扫范围和淋巴结分期。
- 主要结局为癌症特异性生存(CSS),采用 Kaplan-Meier 曲线展示,Cox 比例风险模型评估变量影响。
- 采用 Bonferroni 校正的 log-rank 检验进行 COBRA 评分级别间两两比较,并构建三风险类别的简化 COBRA 评分。
- 通过一致性指数(C-index)、ROC 曲线下面积(AUC)、校准图和决策曲线分析(DCA)比较模型,并与 AJCC 模型对比。
主要发现
- 所有 COBRA 评分变量在 Cox 比例风险模型中均对 CSS 有显著影响。
- COBRA 子评分两两比较未能显著区分所有 COBRA 评分级别。
- 基于上述发现构建简化 COBRA 评分,将 COBRA 评分范围分为低危(0-1)、中危(2-4)、高危(5-7)三类,两两比较可显著区分所有风险类别。
- 与 AJCC 模型比较,AJCC 的 C-index、AUC、校准图和 DCA 均优于原始和简化 COBRA 模型。
关键数值与推荐
- 简化 COBRA 评分风险分类:低危 0-1 分,中危 2-4 分,高危 5-7 分。
- AJCC 模型在 C-index、AUC、校准图和 DCA 上均优于原始和简化 COBRA 模型。
临床怎么用
- COBRA 评分可用于根治性膀胱切除术后 CSS 风险评估,但简化三分类模型区分度更佳。
- AJCC 分期系统应继续作为根治性膀胱切除术后 CSS 分层的标准。
局限性
- COBRA 原始评分各风险组 CSS 存在重叠,区分度欠佳。
- COBRA 及简化 COBRA 模型预测性能均劣于 AJCC 分期系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform an external validation of the Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival (CSS) after radical cystectomy (RC) in a large bi-institutional cohort of patients. PATIENTS AND METHODS: Patients treated with RC and lymph node dissection (LND) between May 1996 and July 2017 were retrieved from the RC databases of Leuven and Turin. Collected variables were age at RC, tumour stage, lymph node (LN) density, neoadjuvant chemotherapy, the extent of LND, and nodal stage. The primary outcome was CSS visualised using Kaplan-Meier plots. Cox proportional hazard models were used to assess the impact of variables on CSS. We performed a pairwise comparison between the COBRA score levels using a log-rank test corrected by Bonferroni, and developed a simplified COBRA score with three risk categories. To compare models, we assessed concordance indices (C-indices), receiver operating characteristic curves with area under the curve (AUC), calibration plots, and decision curve analysis (DCA). Finally, we compared both COBRA and simplified COBRA models with the established American Joint Committee on Cancer (AJCC) model. RESULTS: A total of 812 patients were included. All COBRA score variables had a significant impact on CSS in a Cox proportional hazard model. However, pairwise comparison of the COBRA subscores could not differentiate significantly between all COBRA score levels. Based on these findings, we developed a simplified COBRA score by introducing three categories within the following COBRA score ranges: low- (0-1) vs intermediate- (2-4) vs high-risk (5-7). A pairwise comparison could discriminate significantly between all COBRA risk categories. When finally comparing COBRA and simplified COBRA models with the AJCC model, AJCC performed better than both. C-indices, AUCs, calibration plots and DCA for AJCC were all better compared with the original and simplified COBRA models. CONCLUSION: We performed an external validation of the COBRA score in a large bi-institutional cohort. We observed that several risk groups had overlapping CSS, demonstrating suboptimal performance of the COBRA score. Therefore, we constructed a simplified model with three COBRA score risk categories. This model resulted in demarcated risk groups with non-overlapping CSS and good predictive accuracy. However, both COBRA score models were outperformed by the AJCC staging system. Therefore, we conclude that the AJCC staging system should remain the current standard for stratifying patients after RC for CSS.
引用
- Muilwijk T, Akand M, Soria F, et al. The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort. BJU Int. 2020. PMID: 32640103. doi:10.1111/bju.15163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。